Beauty Health (SKIN) Stock Price, News & Analysis

Company Overview

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

Key Stats

• Today's Range: $1.56 to $1.71
• 50-Day Range: $1.40 to $1.85
• 52-Week Range: $0.91 to $5.17
• Volume: 299,775 shs
• Average Volume: 371,438 shs
• Market Capitalization: $204.80 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.55
• Consensus Rating: Hold

Beauty Health Stock Analysis - MarketRank™

Beauty Health scored higher than 48% of companies evaluated by MarketBeat, and ranked 575th out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Beauty Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 3 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Beauty Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Beauty Health are expected to decrease in the coming year, from ($0.25) to ($0.30) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Beauty Health is -3.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Beauty Health is -3.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Beauty Health has a P/B Ratio of 3.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

9.83% of the float of Beauty Health has been sold short.

Short Interest Ratio / Days to Cover

Beauty Health has a short interest ratio ("days to cover") of 9.5.

Change versus previous month

Short interest in Beauty Health has recently decreased by 6.85%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Beauty Health does not currently pay a dividend.

Dividend Growth

Beauty Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

9.83% of the float of Beauty Health has been sold short.

Short Interest Ratio / Days to Cover

Beauty Health has a short interest ratio ("days to cover") of 9.5.

Change versus previous month

Short interest in Beauty Health has recently decreased by 6.85%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: 0.86

News Sentiment

Beauty Health has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 12 news articles for Beauty Health this week, compared to 17 articles on an average week.

MarketBeat Follows

Only 1 people have added Beauty Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Beauty Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $21,994.00 in company stock.

Percentage Held by Insiders

41.00% of the stock of Beauty Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

93.26% of the stock of Beauty Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SKIN Stock Analysis - Frequently Asked Questions

How have SKIN shares performed this year?

Beauty Health's stock was trading at $1.59 at the beginning of the year. Since then, SKIN stock has increased by 3.8% and is now trading at $1.65.
View the best growth stocks for 2025 here.

How were Beauty Health's earnings last quarter?

The Beauty Health Company (NASDAQ:SKIN) issued its quarterly earnings results on Thursday, May, 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.04. The business's quarterly revenue was down 5.7% on a year-over-year basis.

How do I buy shares of Beauty Health?

Shares of SKIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Beauty Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Beauty Health investors own include Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Company Calendar

• Last Earnings: 5/09/2024
• Today: 1/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SKIN
• CUSIP: N/A
• CIK: 1818093
• Web: hydrafacial.com
• Phone: 800-603-4996
• Fax: N/A
• Employees: 1,030
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $2.55
• High Stock Price Target: $5.00
• Low Stock Price Target: $1.00
• Potential Upside/Downside: +54.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 5 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.42)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-100,120,000.00
• Net Margins: -8.11%
• Pretax Margin: -7.66%
• Return on Equity: -44.83%
• Return on Assets: -3.54%

Debt

• Debt-to-Equity Ratio: 9.23
• Current Ratio: 6.56
• Quick Ratio: 5.57

Sales & Book Value

• Annual Sales: $347.62 million
• Price / Sales: 0.59
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.48 per share
• Price / Book: 3.44

Miscellaneous

• Outstanding Shares: 124,122,000
• Free Float: 73,232,000
• Market Cap: $204.80 million
• Optionable: Optionable
• Beta: 0.85